Turning back the Wheel: Inducing Mesenchymal to Epithelial Transition via Wilms Tumor 1 Knockdown in Human Mesothelioma Cell Lines to Influence Proliferation, Invasiveness, and Chemotaxis
- 4 January 2017
- journal article
- research article
- Published by Springer Nature in Pathology and Oncology Research
- Vol. 23 (4) , 723-730
Abstract
Malignant pleural mesothelioma (MPM) is a highly aggressive tumor that arises from the surface of the pleura and is associated with a history of asbestos exposure. The tumor is characterized by a strong local invasiveness and a poor response to any single modality therapy. Therefore clinical outcome of patients with MPM is poor and median survival time of untreated patients with MPM is 7 months from initial diagnosis. The Wilms Tumor Protein 1 (WT1) is a transcription factor which is highly expressed by MPM and is involved in cellular development and survival. We evaluated the role of WT1 in two human MPM cell lines (MSTO and H2052) expressing high levels of WT1. We performed a knockdown of WT1 using siRNA. Knockdown of WT1 was confirmed by Westernblotting. After knockdown of WT1 we investigated the effect on proliferation, chemoresistance, chemotaxis and migration. We could demonstrate that knockdown of WT1 suppresses chemoresistance in both cell lines compared with control (scrambled siRNA). Additionally, WT1 knockdown reduces proliferation, chemotaxis and invasiveness of mesothelioma cell lines. WT1 reduces malignancy of malignant mesothelioma cell lines and might be a new molecular target in mesothelioma therapy. Further investigations are needed to discover the mechanisms of chemoresistance depending on WT1.Keywords
This publication has 34 references indexed in Scilit:
- Changes in lung function after surgery for mesotheliomaAsian Cardiovascular and Thoracic Annals, 2013
- CC-Chemokine Ligand 18 Induces Epithelial to Mesenchymal Transition in Lung Cancer A549 Cells and Elevates the Invasive PotentialPLOS ONE, 2013
- WT1 silencing by RNAi synergizes with chemotherapeutic agents and induces chemosensitization to doxorubicin and cisplatin in B16F10 murine melanoma cellsOncology Letters, 2012
- WT1 regulates epicardial epithelial to mesenchymal transition through β-catenin and retinoic acid signaling pathwaysDevelopmental Biology, 2011
- Epithelial-to-mesenchymal transition, cell polarity and stemness-associated features in malignant pleural mesotheliomaCancer Letters, 2011
- Wilms’ tumor 1 silencing decreases the viability and chemoresistance of glioblastoma cells in vitro: a potential role for IGF-1R de-repressionJournal of Neuro-Oncology, 2010
- Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype?Nature Reviews Cancer, 2007
- Immunohistochemical marker panels for distinguishing between epithelioid mesothelioma and lung adenocarcinomaPathology International, 2007
- Development of an siRNA-based method for repressing specific genes in renal organ culture and its use to show that the Wt1 tumour suppressor is required for nephron differentiationHuman Molecular Genetics, 2003
- Overexpression of the Wilms' tumor gene WT1 in de novo lung cancersInternational Journal of Cancer, 2002